These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34171391)
1. Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCε/ERK-mediated oxidative stress. Li R; Qi Y; Yuan Q; Xu L; Gao M; Xu Y; Han X; Yin L; Liu C Eur J Pharmacol; 2021 Sep; 907():174277. PubMed ID: 34171391 [TBL] [Abstract][Full Text] [Related]
2. Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKCε Pathway. Ren J; Liu W; Li GC; Jin M; You ZX; Liu HG; Hu Y Curr Med Sci; 2018 Jun; 38(3):405-412. PubMed ID: 30074205 [TBL] [Abstract][Full Text] [Related]
3. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway. Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020 [TBL] [Abstract][Full Text] [Related]
4. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy. Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437 [TBL] [Abstract][Full Text] [Related]
5. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice. Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892 [TBL] [Abstract][Full Text] [Related]
6. Dioscin alleviates myocardial infarction injury via regulating BMP4/NOX1-mediated oxidative stress and inflammation. Zhang Z; Zhao X; Gao M; Xu L; Qi Y; Wang J; Yin L Phytomedicine; 2022 Aug; 103():154222. PubMed ID: 35675750 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal. Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960 [TBL] [Abstract][Full Text] [Related]
9. Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress. Chen HL; Liu Y; Jiang W; Wang XX; Yuan GL; Zhao YL; Yu C Eur J Pharmacol; 2018 Mar; 822():13-24. PubMed ID: 29337195 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Zhao L; Tao X; Qi Y; Xu L; Yin L; Peng J Redox Biol; 2018 Jun; 16():189-198. PubMed ID: 29524841 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation. Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111 [TBL] [Abstract][Full Text] [Related]
12. Dioscin alleviates lung ischemia/reperfusion injury by regulating FXR-mediated oxidative stress, apoptosis, and inflammation. Dong L; Yin L; Li R; Xu L; Xu Y; Han X; Qi Y Eur J Pharmacol; 2021 Oct; 908():174321. PubMed ID: 34252440 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation. Qiao Y; Xu L; Tao X; Yin L; Qi Y; Xu Y; Han X; Tang Z; Ma X; Liu K; Peng J Toxicol Lett; 2018 Mar; 284():37-45. PubMed ID: 29197622 [TBL] [Abstract][Full Text] [Related]
14. β-Adrenergic stimulation activates protein kinase Cε and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy. Li L; Cai H; Liu H; Guo T Mol Med Rep; 2015 Jun; 11(6):4373-80. PubMed ID: 25672459 [TBL] [Abstract][Full Text] [Related]
15. Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115 [TBL] [Abstract][Full Text] [Related]
17. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway. Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365 [TBL] [Abstract][Full Text] [Related]
18. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Liu BY; Li L; Liu GL; Ding W; Chang WG; Xu T; Ji XY; Zheng XX; Zhang J; Wang JX Acta Pharmacol Sin; 2021 May; 42(5):701-714. PubMed ID: 32796955 [TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis. Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576 [TBL] [Abstract][Full Text] [Related]
20. Renal denervation improves mitochondrial oxidative stress and cardiac hypertrophy through inactivating SP1/BACH1-PACS2 signaling. Shen Z; Zhang Y; Bu G; Fang L Int Immunopharmacol; 2024 Nov; 141():112778. PubMed ID: 39173402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]